Search results
APAC leaps ahead in adoptive cell therapy space
Clinical Trials Arena via Yahoo Finance· 6 hours agoThe Asia Pacific (APAC) region is leading the charge for adoptive cell therapy studies, says Scotty Chung-Siu, a managing analyst at GlobalData. At the...
Eyes On Novartis, Gilead, Bristol Myers As FDA Weighs Risks Vs. Benefits Of Approved CAR T-Cell...
Benzinga via Yahoo Finance· 7 months agoTuesday, the FDA said it received reports of patients developing T-cell malignancies, including...
CAR T-Cell Therapies Under FDA Watch on Reports of Malignancies
Zacks via Yahoo Finance· 7 months agoThe FDA has undertaken an investigation of T-cell malignancies in patients undergoing CAR T-cell...
FDA investigating cancer risk linked to CAR-T cell therapy
BioPharma Dive via Yahoo Finance· 7 months agoThe Food and Drug Adminsitration is investigating whether CAR-T cell therapies like Novartis’...
CAR-T for lupus: the ‘tip of the iceberg’ for cell therapy in autoimmune disease
BioPharma Dive via Yahoo Finance· 5 months agoSince a landmark paper in 2022, drugmakers have begun nearly a dozen trials of cell therapies for...
Bristol Myers (BMY) Announces CAR T Cell Therapy Breyanzi Data
Zacks via Yahoo Finance· 12 months agoBristol Myers' (BMY) CAR T cell therapy Breyanzi (lisocabtagene maraleucel) shows deep and durable...
Novartis licenses Legend cell therapy for lung cancer
BioPharma Dive via Yahoo Finance· 7 months agoDive Brief: Novartis is deepening its investment in cancer cell therapy, licensing an experimental...
Bristol Myers (BMY), TSVT CAR T-Cell Therapy to Face FDA's ODAC
Zacks via Yahoo Finance· 4 months agoBristol Myers (BMY) and its partner TSVT announce that the FDA's ODAC will meet in March to review...
EU regulator mandates label updates on CAR-T cancer therapies
Reuters via AOL· 3 days agoThe European Medicines Agency's (EMA) mandate, which echoes the one issued by the U.S. health...
US FDA investigating safety risk of CAR-T cancer therapies
Reuters via AOL· 7 months agoThe U.S. Food and Drug Administration (FDA) said on Tuesday it was investigating cancer therapies...
